Evidence map›Paper›PMID 30382326›Full record

ArticleAnalytical and bioanalytical chemistry2019

3D printed microfluidic devices with immunoaffinity monoliths for extraction of preterm birth biomarkers.

Ellen K Parker, Anna V Nielsen, Michael J Beauchamp, Haifa M Almughamsi, Jacob B Nielsen, Mukul Sonker, Hua Gong, Gregory P Nordin, Adam T Woolley

Open access · greenAbstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. 3D Printed Microfluidics.Annual review of analytical chemistry (Palo Alto, Calif.) · 2020
    Review
  19. Biocompatible PEGDA Resin for 3D Printing.ACS applied bio materials · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ellen K ParkerDepartment of Chemistry and Biochemistry, C100 BNSN, Brigham Young University, Provo, UT, 84602, USA.
Anna V NielsenDepartment of Chemistry and Biochemistry, C100 BNSN, Brigham Young University, Provo, UT, 84602, USA.
Michael J BeauchampDepartment of Chemistry and Biochemistry, C100 BNSN, Brigham Young University, Provo, UT, 84602, USA.
Haifa M AlmughamsiDepartment of Chemistry and Biochemistry, C100 BNSN, Brigham Young University, Provo, UT, 84602, USA.
Jacob B NielsenDepartment of Chemistry and Biochemistry, C100 BNSN, Brigham Young University, Provo, UT, 84602, USA.
Mukul SonkerDepartment of Chemistry and Biochemistry, C100 BNSN, Brigham Young University, Provo, UT, 84602, USA.
Hua GongDepartment of Electrical and Computer Engineering, 450G EB, Brigham Young University, Provo, UT, 84602, USA.
Gregory P NordinDepartment of Electrical and Computer Engineering, 450G EB, Brigham Young University, Provo, UT, 84602, USA.
Adam T WoolleyDepartment of Chemistry and Biochemistry, C100 BNSN, Brigham Young University, Provo, UT, 84602, USA. atw@byu.edu.
Brigham Young University · US

Funding

Phase-Changing Sacrificial Layer Microfluidics for Enhanced Protein AnalysisR01EB006124 · NIBIB · BRIGHAM YOUNG UNIVERSITY · PI WOOLLEY, ADAM THOMAS · 2006 to 2016
$3.1M
High Density 3D Printed Microfluidics With Open Source Resins for Biomedical ApplicationsR15GM123405 · NIGMS · BRIGHAM YOUNG UNIVERSITY · PI NORDIN, GREGORY P. · 2017 to 2023
$1.3M
3D-Printed Integrated Microfluidic Devices for Preterm Birth Biomarker AnalysisR01EB027096 · NIBIB · BRIGHAM YOUNG UNIVERSITY · PI WOOLLEY, ADAM THOMAS · 2018 to 2021
$1.1M
National Institute of Biomedical Imaging and Bioengineering R01 EB006124National Institute of Biomedical Imaging and Bioengineering R01 EB027096National Institute of General Medical Sciences R15 GM123405National Institute of General Medical Sciences R15GM123405-01A1NIBIB NIH HHS R01 EB006124NIGMS NIH HHS R15 GM123405
6 · The paper itself

Abstract

Preterm birth (PTB) is defined as birth before the 37th week of pregnancy and results in 15 million early deliveries worldwide every year. Presently, there is no clinical test to determine PTB risk; however, a panel of nine biomarkers found in maternal blood serum has predictive power for a subsequent PTB. A significant step in creating a clinical diagnostic for PTB is designing an automated method to extract and purify these biomarkers from blood serum. Here, microfluidic devices with 45 μm × 50 μm cross-section channels were 3D printed with a built-in polymerization window to allow a glycidyl methacrylate monolith to be site-specifically polymerized within the channel. This monolith was then used as a solid support to attach antibodies for PTB biomarker extraction. Using these functionalized monoliths, it was possible to selectively extract a PTB biomarker, ferritin, from buffer and a human blood serum matrix. This is the first demonstration of monolith formation in a 3D printed microfluidic device for immunoaffinity extraction. Notably, this work is a crucial first step toward developing a 3D printed microfluidic clinical diagnostic for PTB risk.

Indexed as

Lab-On-A-Chip DevicesPremature BirthBiomarkersFemaleHumansInfant, NewbornPolymerizationPregnancyPrinting, Three-DimensionalBiomarkers3D printingIntegrated microfluidicsMonolithsPoint-of-careSample preparationSample purification

Identifiers

PMID30382326
PMCPMC6494739
OpenAlexW2898653028

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.